Results 71 to 80 of about 85,679 (96)

Which heart failure phenotypes benefit from GLP-1 receptor agonists? [PDF]

Cardiovasc Diabetol Endocrinol Rep
Deng J.
europepmc   +1 more source

Reappraising obesity management in the GLP-1 receptor agonist era. [PDF]

NPJ Metab Health Dis
Christmas T, Ahmed AR, Tan TM.
europepmc   +1 more source

Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study. [PDF]

PLoS One
Kazi MAI, Mufarrih SM, Sirohi A, Hasan F, Sharma A, Singh S, Muganlinskaya N, Haq N.   +7 more
europepmc   +1 more source

Diabetes Mellitus and Stroke: Pathophysiological Connections and Therapeutic Potential of GLP-1 and GLP-1/GIP Receptor Agonists. [PDF]

Pharmaceutics
Paceana MA, Tartau LM, Boboc IKS, Oancea CN, Berbecaru-Iovan A, Foia CI, Tartau CG, Bogdan M.   +7 more
europepmc   +1 more source

GLP-1 receptor agonists in cardiovascular disease: a guide for cardiologists. [PDF]

Br J Cardiol
Ayton SL, Papamargaritis D, Davies MJ, McCann GP, Gulsin GS.   +4 more
europepmc   +1 more source

GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction. [PDF]

Biol Psychiatry Glob Open Sci
Reitz J, Rosoff DB, Pacher P, Lohoff FW.
europepmc   +1 more source

Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists. [PDF]

Diabetes Obes Metab
Chen SC, Wang TJ, Chou CK, Lee C.
europepmc   +1 more source

GLP-1 Receptor Agonists and Fertility: What Is Known So Far? [PDF]

JBRA Assist Reprod
Becker AS, Castilhos JP, Shugair SAS, Colombo T, Hentschke M-.   +4 more
europepmc   +1 more source

Effects of GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]

Diabetes Obes Metab
Kanbay M, Shah E, AlShiab R, Ozbek L, Ay S, Rustamov A, Covic A, Mallamaci F, Zoccali C.   +8 more
europepmc   +1 more source

GLP-1 Receptor Agonist Use in Cancer Survivors-Challenges and Opportunities: A Narrative Review. [PDF]

Cancers (Basel)
Agurs-Collins T, Sauter ER.
europepmc   +1 more source